Speaker Profile
Tudor I. Oprea

Tudor I. Oprea MD, PhD

Internal Medicine and General Medicine, Biotechnology, Bioinformatics
Albuquerque, New Mexico, United States of America

Connect with the speaker?

Dr. Oprea has disclosed 19 inventions, received four issued U. S. patents, has four pending patent applications, an option to license agreement with local start-up company Accelera Diagnostics, LLC, and a license agreement with local start-up Azano Biotech for several compounds for the diagnosis and treatment of cancers.

Dr. Oprea’s technologies are focused on integrating chemical and biomedical informatics and the application of knowledge management and data mining in drug discovery and repurposing, with a focus on small molecules, translational-research informatics, and health-record data mining. He and his co-inventors successfully identified selective, potent compounds for a number of biologically important targets, which include GPER (the G-protein estrogen receptor), the formyl peptide receptors FPR1 and FPR2, the small GTPases Rac1 and Cdc42, and the ABCG2 efflux transporter. Dr. Oprea’s work has led to clinical trials for Raltegravir, an anti-AIDS medicine, and Ketorolac, a non-steroidal anti-inflammatory drug, both studied as anti-cancer agents at the UNM Cancer Center.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)